TWI PHARMACEUTICALS INC

Business Nature: Manufacturer

Company Profile:

TWI Pharmaceuticals Inc. is a leading specialty pharmaceutical company based in Taiwan, primarily focused on the development, manufacturing, and commercialization of complex generic drugs and high-barrier specialty products. The company specializes in advanced drug delivery technologies, including controlled-release formulations and difficult-to-manufacture dosage forms. With state-of-the-art R&D facilities and GMP-certified manufacturing plants, TWI Pharmaceuticals maintains a strong presence in international markets, particularly in the United States. The company is dedicated to providing high-quality, affordable healthcare solutions through rigorous scientific research and regulatory compliance.

TWI Pharmaceuticals Inc. (Taiwan) produces or sells the following products:

Minocycline Foam (for acne)

Ivermectin Topical Cream (for rosacea)

Tretinoin Cream (for acne)

Mometasone Furoate Foam (for psoriasis)

Clindamycin Phosphate Topical Foam (for acne)

Azelaic Acid Topical Foam (for rosacea and acne)

Diclofenac Topical Gel (for actinic keratosis)

Betamethasone Valerate Topical Foam (for corticosteroid-responsive dermatoses)

Finasteride Topical Spray (in development for androgenetic alopecia)

Fingolimod Oral Solution (generic for multiple sclerosis)

Droxidopa Capsules (generic for neurogenic orthostatic hypotension)

Rivastigmine Transdermal Patch (generic for Alzheimer's disease)

Budesonide Oral Suspension (for eosinophilic esophagitis)